Vivanza Biosciences Limited has filed a non-applicability statement with BSE Limited regarding compliance requirements under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company confirmed that it has not undertaken any fund-raising activities that would necessitate filing a deviation statement.

Regulatory Compliance Communication

The communication, dated 14th April, 2026, was addressed to the Department of Corporate Services at BSE Limited. The statement pertains to Regulation 32 of SEBI LODR Regulations, which requires companies to submit statements regarding any deviations or variations from the proceeds of various fund-raising activities.

Fund Raising Activities Status

Vivanza Biosciences confirmed that the company has not raised any funds through the following methods:

• Public Issue
• Rights Issue
• Preferential Issue
• Qualified Institutions Placement (QIP)

Due to the absence of such fund-raising activities, the company stated that the Statement of Deviation or Variation requirement is not applicable.

Company Information

The communication includes standard corporate details with the company's registered office located at 403, Sarthik 2, Opp. Rajpath Club, S. G. Highway, Ahmedabad 380054. The filing was digitally signed by Company Secretary & Compliance Officer Chaitra Arora on 14th April, 2026, at 15:38:55 +05'30'.

This regulatory filing demonstrates the company's commitment to maintaining transparency and compliance with SEBI's disclosure requirements, even when specific regulations are not applicable to their current business activities.

Vivanza Biosciences Limited has filed its mandatory annual disclosure under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations 2011 for the financial year ended March 31, 2026. The disclosure was submitted to BSE Limited on April 9, 2026, in compliance with Regulation 31(4) requirements.

Promoter Shareholding Details

The disclosure reveals the shareholding positions of the company's promoters as of March 31, 2026. Both promoters have confirmed their holdings and declared no encumbrance activities during the financial year.

Regulatory Compliance

The annual disclosure under Regulation 31(4) of SEBI SAST Regulations 2011 is a mandatory requirement for promoters of listed companies. This regulation ensures transparency in shareholding patterns and any changes in substantial acquisitions or disposals by promoters.

Key compliance highlights include:

• Filing Date: April 9, 2026
• Reporting Period: Financial Year ended March 31, 2026
• Regulatory Framework: SEBI (SAST) Regulations 2011
• Declaration: No encumbrance of shares by either promoter during FY26

Company Information

Vivanza Biosciences Limited, incorporated in 1982, operates from its registered office in Ahmedabad, Gujarat. The company is led by Managing Director Jayendra Mehta, who signed the disclosure filing on behalf of the company. The filing confirms the company's commitment to maintaining regulatory compliance and transparency in its shareholding disclosures.

Both promoters submitted individual declarations confirming their respective shareholdings and stating that no direct or indirect encumbrance of shares occurred during the financial year ended March 31, 2026.